arznei-telegramm Logo a-t Kurzlogo
    ❮ a-t 4/2014 a-t ❯
    This is a translation of the table of contents. One article of each issue is translated and freely available.
    table of contents
    SPOT ON

    Sofosbuvir (SOVALDI) for hepatitis C - progress with insufficient data

    NEW ON THE MARKET

    PDE5 inhibitor No 4: Avanafil (SPEDRA) against erectile dysfunction

    THERAPY FROM A CRITICAL VIEWPOINT

    Renal denvervation for refractory hypertension - not outside clinical trials

    REVIEW

    Tick-borne encephalitis (I)

    a-t READER'S QUESTIONS AND COMMENTS

    Antidiarrheal racecadotril (TIORFAN, VAPRINO)

    IN BRIEF

    St. John's wort - pregnant despite IMPLANON

    Drug advertisement - is it enough to be a little critical?

    Level of phenylephrine increased fourfold in combination with paracetamol

    CURRENT ADR NETWORK REPORT

    Liver injury with pregabalin (LYRICA)
    free

    SIDE EFFECTS

    Macrolides: a risk factor for hypertrophic pyloric stenosis

    e a-t IN INTERNET

    Sofosbuvir (SOVALDI) against chronic hepatitis C

    arznei-telegramm

    Independent drug information – in English

    Concise, critical evaluations of drugs and medical devices for evidence-based therapy and patient advice on benefits and risks – independent, ad-free and funded exclusively by subscriptions.

    Browse free articles